R&D
Supercharging clinical development with RWE – with Recursion...
Greater availability of real-world data and real-world evidence is rapidly changing the landscape of drug development.
Digital
“Data is our currency” – with Ginkgo Datapoints’ John Andros...
Successful use of AI is becoming a key differentiator for pharma companies.
Patients
New Boehringer US Head Brian Hilberdink talks GLP-1s, DTx an...
At Reuters Pharma USA, editor-in-chief Jonah Comstock caught up with Brian Hilberdink, the new head of US human pharma at Boehringer Ingelheim.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
